Cargando…

The use of advanced‐platelet rich fibrin (A‐PRF) in the management of medication‐related osteonecrosis of the jaw (MRONJ): A case report

Medication‐related osteonecrosis of the jaws (MRONJ) is a serious debilitating disease resulting from long‐term treatment with Antiresorptive drugs such as Bisphosphonates or Denosumab, which significantly affects patients' quality of life. A 43‐year‐old female patient with stage 4 breast cance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asfour, Maan Ahmad Rafik, Aljoujou, Abeer Ahmad, Saifo, Maher Sadik, Jabban, Haya A. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675097/ https://www.ncbi.nlm.nih.gov/pubmed/38028038 http://dx.doi.org/10.1002/ccr3.8259

Ejemplares similares

The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Miranda, Michele, et al.
Publicado: (2021)

The role of Leucocyte-rich and platelet-rich fibrin (L-PRF) in the treatment of the medication-related osteonecrosis of the jaws (MRONJ)
por: Cano-Durán, Jorge A., et al.
Publicado: (2017)

Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Leukocyte- and Platelet-Rich Fibrin (L-PRF) and Photobiomodulation: A Retrospective Study
por: Tenore, Gianluca, et al.
Publicado: (2020)

Complementarity of surgical therapy, photobiomodulation, A-PRF and L-PRF for management of medication-related osteonecrosis of the jaw (MRONJ): an animal study
por: Jamalpour, Mohammad Reza, et al.
Publicado: (2022)

Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ)
por: Berg, Britt-Isabelle, et al.
Publicado: (2016)

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Kwon, Yong-Dae, et al.
Publicado: (2016)

The potential application of platelet-rich fibrin (PRF) in vestibuloplasty
por: Amiri, Mohammad Amin, et al.
Publicado: (2021)

Nutritional Status in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Laimer, Johannes, et al.
Publicado: (2021)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Otto, Sven, et al.
Publicado: (2021)

Association between Hyperglycemia and Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Kammerhofer, Gabor, et al.
Publicado: (2023)

Medication related osteonecrosis of the jaws (MRONJ): Factors related to recurrence after treatment with surgery and platelet rich plasma (PRP) placement
por: Sánchez-Gallego Albertos, Celia, et al.
Publicado: (2021)

Quantitative Near-Infrared Imaging of Platelets in Platelet-Rich Fibrin (PRF) Matrices: Comparative Analysis of Bio-PRF, Leukocyte-Rich PRF, Advanced-PRF and Concentrated Growth Factors
por: Aizawa, Hachidai, et al.
Publicado: (2020)

Comparison of Antimicrobial Activity of Injectable Platelet-Rich Fibrin (i-PRF) and Leukocyte and Platelet-Rich Fibrin (l-PRF) Against Oral Microbes: An In Vitro Study
por: Sindhusha, Vyshnavi B, et al.
Publicado: (2023)

Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ)
por: Almousa, Mandlin Abdulaziz, et al.
Publicado: (2021)

Oral Complications in Cancer Patients–Medication-Related Osteonecrosis of the Jaw (MRONJ)
por: Migliorati, Cesar Augusto
Publicado: (2022)

Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ)
por: Yan, Ran, et al.
Publicado: (2022)

Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw
por: Cortese, Antonio, et al.
Publicado: (2021)

Pathological fracture of the coronoid process secondary to medication-related osteonecrosis of the jaw (MRONJ)
por: Jowett, Adam, et al.
Publicado: (2015)

Medication-Related Osteonecrosis of the Jaw (MRONJ) due to Simvastatin: An Unusual Case Report
por: Samieirad, Sahand, et al.
Publicado: (2021)

Treatment of bone defects with bovine hydroxyapatite xenograft and platelet rich fibrin (PRF) to accelerate bone healing
por: Taufik S, Ahmad, et al.
Publicado: (2022)

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020
por: Campisi, Giuseppina, et al.
Publicado: (2020)

Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Nica, Diana Florina, et al.
Publicado: (2021)

Conservative Management of Medication-Related Osteonecrosis of the Jaws (MRONJ): A Retrospective Cohort Study
por: Varoni, Elena M., et al.
Publicado: (2021)

Macrophage Involvement in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Comprehensive, Short Review
por: Gkouveris, Ioannis, et al.
Publicado: (2022)

Medication-Related Osteonecrosis of the Jaws (MRONJ) in Children and Young Patients—A Systematic Review
por: Rosales, Hemil Dario, et al.
Publicado: (2023)

Leukocyte and platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: A systematic review and meta-analysis
por: Muñoz-Salgado, Ana, et al.
Publicado: (2023)

Prevention and management of drug‐induced osteonecrosis of the jaws using platelet‐rich fibrin: A clinical feasibility study
por: Alrmali, Abdusalam, et al.
Publicado: (2023)

Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan
por: Shibahara, Takahiko
Publicado: (2019)

Platelet Rich Fibrin (PRF) and Its Related Products: Biomolecular Characterization of the Liquid Fibrinogen
por: Serafini, Giorgio, et al.
Publicado: (2020)

Platelet-rich fibrin (PRF) gel modified by a carbodiimide crosslinker for tissue regeneration
por: Karimi, Fatemeh, et al.
Publicado: (2022)

Evaluation of advanced platelet-rich fibrin (PRF) as a bio-carrier for ampicillin/sulbactam
por: Straub, Anton, et al.
Publicado: (2022)

Extraction Socket Augmentation with Autologous Platelet-Rich Fibrin (PRF): The Rationale for Socket Augmentation
por: Ucer, Cemal, et al.
Publicado: (2023)

Alveolar Ridge Preservation with Autologous Platelet-Rich Fibrin (PRF): Case Reports and the Rationale
por: Ucer, Cemal, et al.
Publicado: (2023)

Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study
por: Okuyama, Kohei, et al.
Publicado: (2021)

Reporting Criteria for Clinical Trials on Medication-Related Osteonecrosis of the Jaw (MRONJ): A Review and Recommendations
por: Gaudet, Camille, et al.
Publicado: (2022)

Radiographic Evaluation of Medication-Related Osteonecrosis of the Jaw (MRONJ) With Different Primary Cancers and Medication Therapies
por: Muttanahally, Kavya Shankar, et al.
Publicado: (2023)

Promising results of surgical management of advanced medication related osteonecrosis of the jaws using adjunctive leukocyte and platelet rich fibrin
por: Özalp, Öznur, et al.
Publicado: (2021)

The use of platelet-rich fibrin (PRF) and PRF-mixed particulated autogenous bone graft in the treatment of bone defects: An experimental and histomorphometrical study
por: Kökdere, Nesligül Niyaz, et al.
Publicado: (2015)

Tensile Strength Essay Comparing Three Different Platelet-Rich Fibrin Membranes (L-PRF, A-PRF, and A-PRF+): A Mechanical and Structural In Vitro Evaluation
por: Simões-Pedro, Mara, et al.
Publicado: (2022)

Enhancing Fat Graft Survival With Autologous Growth Factors: Platelet-Rich Fibrin (PRF) vs Platelet-Rich Plasma (PRP)
por: Nolan, Grant S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_korf374lffrje83oiojohoulhs